NCT04375267 2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1 Completed
Clinical Trials
21 trialsNCT06971848 2026-03-30
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT05701527 2026-02-05
A Study of EBC-129 in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Recruiting
NCT07313202 2025-12-31
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT02078700 2025-06-25
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT06969742 2025-05-14
Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers
National Cancer Center, Korea
Phase NA Recruiting
NCT06955390 2025-05-02
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT05649618 2022-12-14
TIL Cells for the Treatment of the Advanced Solid Tumors Patients
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT05648994 2022-12-13
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT05380986 2022-05-19
Camrelizumab Combined With Apatinib Mesylate
Henan Cancer Hospital
Phase NA Unknown
NCT03551795 2022-05-09
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Completed
NCT04832204 2021-04-05
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Beijing Hospital
Phase 2 Unknown
NCT04175899 2021-03-08
POCCP1
Ministry of Health, Malaysia
Phase NA Unknown
NCT03412357 2020-09-16
MesoTRAP
Papworth Hospital NHS Foundation Trust
Phase NA Completed
NCT02950103 2019-09-30
Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients
Secretaria de Estado da Saúde
Phase 2 Terminated
NCT03068117 2019-06-13
RESPECT-Meso
Portsmouth Hospitals NHS Trust
Phase NA Completed
NCT03975036 2019-06-05
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
Henan Cancer Hospital
Phase 2/3 Unknown
NCT00821860 2013-06-28
MesoVATS
Papworth Hospital NHS Foundation Trust
Phase 3 Completed
NCT00886028 2009-04-22
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
National Institute of Cancerología
Phase 2 Unknown
NCT00460876 2008-05-02
Phase I Trial of Periocular Topotecan in Retinoblastoma
Hospital JP Garrahan
Phase 1 Completed
NCT00404508 2006-11-28
A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors
National Institute of Cancerología
Phase 2 Completed